High Note Wealth’s Amgen AMGN Stock Holding History

High Note Wealth’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$186K	Sell	514 -5	-1%	-$1.71K	0.03%	123
2026 Q1	$183K	Buy	519 +11	+2%	+$3.92K	0.04%	112
2025 Q4	$166K	Buy	508 +28	+6%	+$8.88K	0.03%	115
2025 Q3	$135K	Buy	480 +1	+0.2%	+$290	0.03%	122
2025 Q2	$134K	Hold	479	–	–	0.03%	121
2025 Q1	$149K	Sell	479 -25	-5%	-$7.38K	0.04%	110
2024 Q4	$131K	Buy	+504	New	+$150K	0.03%	117

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

High Note Wealth's AMGN Position: Q2 2026 in Review

High Note Wealth reduced its Amgen (AMGN) stake by 0.96% in Q2 2026, selling an estimated $1.71K and leaving 514 shares worth $186K. The position accounts for 0.03% of the portfolio, ranked #123.

High Note Wealth first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

High Note Wealth held 514 shares of Amgen worth $186K as of Q2 2026.
High Note Wealth sold 5 Amgen shares in Q2 2026, an estimated $1.71K.
Amgen made up 0.03% of High Note Wealth's portfolio in Q2 2026, its #123 holding.
High Note Wealth first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on High Note Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.